Interestingly, the validated targets of the RRMS-relapse-specific miRNAs did not include some of the genes most implicated in MS pathophysiology, e.g., IFNG, TNFR1, IL7R, and IL2RA [4]. The gene discussed is IFNG; the disease is myeloid sarcoma.